Fertility and Sterility
Volume 95, Issue 1 , Pages 320-323 , January 2011

Periodontal disease in polycystic ovary syndrome

  • Erhan Dursun, D.D.S.

      Affiliations

    • Department of Periodontology, School of Dentistry, Hacettepe University, Ankara, Turkey
    • ,
  • Ferda Alev Akalın, D.D.S., Ph.D.

      Affiliations

    • Department of Periodontology, School of Dentistry, Hacettepe University, Ankara, Turkey
    • ,
  • Güliz Nigar Güncü, D.D.S., Ph.D.

      Affiliations

    • Department of Periodontology, School of Dentistry, Hacettepe University, Ankara, Turkey
    • ,
  • Nese Çınar, M.D.

      Affiliations

    • Endocrinology and Metabolism Unit, Department of Internal Medicine, School of Medicine, Hacettepe University, Ankara, Turkey
    • ,
  • Duygu Yazgan Aksoy, M.D.

      Affiliations

    • Endocrinology and Metabolism Unit, Department of Internal Medicine, School of Medicine, Hacettepe University, Ankara, Turkey
    • ,
  • Tolga Fikret Tözüm, D.D.S., Ph.D.

      Affiliations

    • Department of Periodontology, School of Dentistry, Hacettepe University, Ankara, Turkey
    • ,
  • Kamer Kılınc, M.D.

      Affiliations

    • Department of Biochemistry, School of Medicine, Hacettepe University, Ankara, Turkey
    • ,
  • Bülent Okan Yıldız, M.D.

      Affiliations

    • Endocrinology and Metabolism Unit, Department of Internal Medicine, School of Medicine, Hacettepe University, Ankara, Turkey
    • Corresponding Author InformationReprint requests: Bülent Okan Yıldız, M.D., Endocrinology and Metabolism Unit, Department of Internal Medicine, Hacettepe University School of Medicine, 06100, Sıhhiye, Ankara, Turkey (FAX: 90-312-2322518).

Received 8 May 2010 ,Revised 19 June 2010 ,Accepted 8 July 2010.

References 

  1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745–2749
  2. Sam S, Dunaif A. Polycystic ovary syndrome: syndrome XX?. Trends Endocrinol Metab. 2003;14:365–370
  3. Williams RC. Periodontal disease. N Engl J Med. 1990;322:373–382
  4. D'Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J, et al. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab. 2008;93:3989–3994
  5. Kinane D, Bouchard P. Periodontal diseases and health: consensus report of the Sixth European Workshop on Periodontology. J Clin Periodontol. 2008;35:333–337
  6. Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, Battino M. Metabolic syndrome and periodontitis: is oxidative stress a common link?. J Dent Res. 2009;88:503–518
  7. Chapple IL, Matthews JB. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 2000. 2007;43:160–232
  8. Uitto VJ. Gingival crevice fluid—an introduction. Periodontol 2000. 2003;31:9–11
  9. Rudin HJ, Overdiek HF, Rateitschak KH. Correlation between sulcus fluid rate and clinical and histological inflammation of the marginal gingiva. Helv Odontol Acta. 1970;14:21–26
  10. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Rotterdam ESHRE/ASRM–Sponsored PCOS Consensus Workshop Group. Fertil Steril. 2004;81:19–25
  11. Yildiz BO, Haznedaroglu IC, Kirazli S, Bayraktar M. Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state. J Clin Endocrinol Metab. 2002;87:3871–3875
  12. Newman MG, Takei HH, Klokkevold PR, Carranza FA. Clinical periodontology. 10th ed.. St. Louis, MO: Saunders Elsevier; 2009;552–3
  13. Loe H. The gingival index, the plaque index and the retention index systems. J Periodontol. 1967;38(Suppl):610–616
  14. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condtion. Acta Odontol Scand. 1964;22:121–135
  15. Yildiz BO, Bozdag G, Harmanci A, Otegen U, Boynukalin K, Vural Z, et al. Increased circulating soluble P-selectin in polycystic ovary syndrome. Fertil Steril; 93:2311–5.
  16. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem. 1983;132:345–352
  17. Grisham MB, Johnson GG, Lancaster JR. Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol. 1996;268:237–246
  18. Schatzle M, Loe H, Burgin W, Anerud A, Boysen H, Lang NP. Clinical course of chronic periodontitis. I. Role of gingivitis. J Clin Periodontol. 2003;30:887–901
  19. Nishida N, Tanaka M, Hayashi N, Nagata H, Takeshita T, Nakayama K, et al. Determination of smoking and obesity as periodontitis risks using the classification and regression tree method. J Periodontol. 2005;76:923–928
  20. Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC, et al. Noninsulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol. 1998;69:76–83
  21. Yildiz BO, Knochenhauer ES, Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93:162–168
  22. The pathogenesis of periodontal diseases. J Periodontol. 1999;70:457–470
  23. Akalin FA, Baltacioglu E, Alver A, Karabulut E. Lipid peroxidation levels and total oxidant status in serum, saliva and gingival crevicular fluid in patients with chronic periodontitis. J Clin Periodontol. 2007;34:558–565
  24. Sculley DV, Langley-Evans SC. Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation. Clin Sci (Lond). 2003;105:167–172
  25. Wei PF, Ho KY, Ho YP, Wu YM, Yang YH, Tsai CC. The investigation of glutathione peroxidase, lactoferrin, myeloperoxidase and interleukin-1beta in gingival crevicular fluid: implications for oxidative stress in human periodontal diseases. J Periodontal Res. 2004;39:287–293
  26. Yamalik N, Caglayan F, Kilinc K, Kilinc A, Tumer C. The importance of data presentation regarding gingival crevicular fluid myeloperoxidase and elastase-like activity in periodontal disease and health status. J Periodontol. 2000;71:460–467
  27. Kuscu NK, Var A. Oxidative stress but not endothelial dysfunction exists in nonobese, young group of patients with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2009;88:612–617
  28. Nacul AP, Andrade CD, Schwarz P, de Bittencourt PI, Spritzer PM. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity. Eur J Obstet Gynecol Reprod Biol. 2007;133:191–196
  29. Gonzalez F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:336–340
  30. Diamanti-Kandarakis E, Katsikis I, Piperi C, Kandaraki E, Piouka A, Papavassiliou AG, et al. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2008;69:634–641

 E.D. has nothing to disclose. F.A.A. has nothing to disclose. G.N.G. has nothing to disclose. N.C. has nothing to disclose. D.Y.A. has nothing to disclose. T.F.T. has nothing to disclose. K.K. has nothing to disclose. B.O.Y. has nothing to disclose.

 Supported by Hacettepe University grant no. 0701101017.

PII: S0015-0282(10)02158-8

doi: 10.1016/j.fertnstert.2010.07.1052

Fertility and Sterility
Volume 95, Issue 1 , Pages 320-323 , January 2011

Article Tools